How many institutions held ABUS - Arbutus Biopharma Corp - Common Shares, without par value in Q2 2019?

56 institutional investors reported ABUS - Arbutus Biopharma Corp - Common Shares, without par value for Q2 2019. Use the holders table for investor-level position and value details.

Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Q: What does CUSIP 03879J100 represent in this 13F holders report?

CUSIP 03879J100 is the security identifier for ABUS - Arbutus Biopharma Corp - Common Shares, without par value used to aggregate holder disclosures.

CUSIP: 03879J100

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Shares, without par value
Shares outstanding: 197,420,670
Total 13F shares: 21,113,616
Share change: -2,866,476
Total reported value: $43,982,113
Put/Call ratio: 165%
Price per share: $2.08
Number of holders: 56
Value change: -$11,240,138
Number of buys: 32
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 03879J100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	2.8%	5,510,223	$19,727,000	—	31 Mar 2019	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	2%	4,040,900	$14,466,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	1.2%	2,312,132	$8,278,000	—	31 Mar 2019	13F
EcoR1 Capital, LLC	13F	Company	1.1%	2,172,883	$7,779,000	—	31 Mar 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0.89%	1,765,315	$6,320,000	—	31 Mar 2019	13F
BANK OF MONTREAL /CAN/	13F	Company	0.5%	979,124	$3,505,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.49%	965,931	$3,458,000	—	31 Mar 2019	13F
Foresite Capital Management IV, LLC	13F	Company	0.41%	804,446	$2,880,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.39%	777,470	$2,784,000	—	31 Mar 2019	13F
Hudson Bay Capital Management LP	13F	Company	0.33%	650,000	$2,327,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	0.29%	574,476	$2,057,000	—	31 Mar 2019	13F
NORGES BANK	13F	Company	0.19%	369,720	$1,324,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.16%	313,760	$1,123,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	0.14%	282,626	$1,012,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	262,990	$941,000	—	31 Mar 2019	13F
DAFNA Capital Management LLC	13F	Company	0.13%	246,900	$884,000	—	31 Mar 2019	13F
BAILARD, INC.	13F	Company	0.12%	228,000	$816,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	220,650	$790,000	—	31 Mar 2019	13F
ALPS ADVISORS INC	13F	Company	0.07%	134,053	$480,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	131,154	$468,000	—	31 Mar 2019	13F
S.c.a. Candriam	13F	Individual	0.05%	105,000	$376,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.05%	97,928	$350,000	—	31 Mar 2019	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.02%	34,500	$311,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.04%	75,945	$272,000	—	31 Mar 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.04%	71,560	$256,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.03%	69,076	$247,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	65,900	$236,000	—	31 Mar 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.03%	63,334	$227,000	—	31 Mar 2019	13F
SG Americas Securities, LLC	13F	Company	0.03%	57,454	$206,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	54,700	$196,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	53,938	$193,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	48,597	$174,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.02%	48,047	$172,000	—	31 Mar 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	47,300	$169,000	—	31 Mar 2019	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.02%	45,924	$164,000	—	31 Mar 2019	13F
MACKENZIE FINANCIAL CORP	13F	Company	0.02%	39,900	$143,000	—	31 Mar 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	35,600	$127,000	—	31 Mar 2019	13F
PDT Partners, LLC	13F	Company	0.02%	30,200	$108,000	—	31 Mar 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.01%	28,128	$101,000	—	31 Mar 2019	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	26,188	$93,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	24,500	$88,000	—	31 Mar 2019	13F
SCOTIA CAPITAL INC.	13F	Company	0.01%	22,850	$82,000	—	31 Mar 2019	13F
ProShare Advisors LLC	13F	Company	0.01%	22,682	$81,000	—	31 Mar 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	22,516	$81,000	—	31 Mar 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.01%	21,796	$78,000	—	31 Mar 2019	13F
BARCLAYS PLC	13F	Company	0.01%	15,145	$54,000	—	31 Mar 2019	13F
Seelaus Asset Management LLC	13F	Company	0.01%	14,300	$51,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	14,225	$51,000	—	31 Mar 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	13,404	$48,000	—	31 Mar 2019	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.01%	12,700	$45,000	—	31 Mar 2019	13F

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q2 2019

As of 30 Jun 2019, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,113,616 shares. The largest 10 holders included RTW INVESTMENTS, LP, PRIMECAP MANAGEMENT CO/CA/, LADENBURG THALMANN FINANCIAL SERVICES INC., MORGAN STANLEY, BANK OF MONTREAL /CAN/, Hudson Bay Capital Management LP, BlackRock Inc., JENNISON ASSOCIATES LLC, Foresite Capital Management IV, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

-8

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.